Exclusion criteria

Related by string. * Exclusions . exclusions . EXCLUSION . exclusion : exclusion override . homestead exclusion . exclusion zone . THE EXCLUSION OR LIMITATION . categorical exclusions . categorical exclusion / CRITERIA . criterias . Criteria : Downgrade Criteria June . Common Criteria certification . DSM IV criteria . qualitative criteria . Fitch Revises Rating Criteria . Downgrade Criteria * *

Related by context. All words. (Click for frequent words.) 69 Postoperative complications 67 neutropenia thrombocytopenia 67 neurologic abnormalities 67 haematologic 67 headache abdominal pain 66 hepatic enzyme 66 pathologic fractures 66 affective psychosis 66 Primary endpoints 66 psychiatric comorbidities 66 coronary stenosis 65 generalized tonic clonic seizures 65 Dose limiting toxicities 65 headache nasopharyngitis 65 Adverse effects 65 TEAEs 65 hypophosphatemia 65 Secondary endpoints 64 Secondary efficacy endpoints 64 autonomic dysfunction 64 postintervention 64 comorbid depression 64 CTEPH 64 syncopal 64 paresthesias 64 procedural sedation 64 unresectable HCC 64 hypersensitivity reactions eg anaphylaxis 64 nondiabetic patients 64 gross hematuria 64 artery occlusion 64 neurologic symptoms 64 neurologic dysfunction 64 headache nausea diarrhea 63 nasopharyngitis headache 63 extrapyramidal symptoms 63 COPD exacerbation 63 hypopneas 63 subarachnoid hemorrhage SAH 63 retrograde ejaculation 63 nontraumatic 63 cytopenias 63 ALT flares 63 hematological adverse 63 radiographic findings 63 nasal polyposis 63 granulomatous 63 Serious adverse reactions 63 obscure gastrointestinal bleeding 63 hyperreflexia 63 lipid lowering agents 63 cerebrovascular accidents 63 postoperative complication 63 anemia neutropenia 63 deep vein thromboses 63 Complication rates 63 receiving XGEVA 63 nausea vomiting headache 63 hypogonadotropic hypogonadism 63 affective disorders 63 lacunar 63 liver transaminases 63 saline infusion 62 postoperative AF 62 neurologic outcomes 62 apnea hypopnea 62 pericardial effusion 62 femoral neck fracture 62 NNT = 62 hemodynamically significant 62 SIADH 62 â ‰ ¥ 62 urolithiasis 62 lenalidomide dexamethasone 62 parkinsonian 62 headache nausea fatigue 62 cervicitis 62 sonographic findings 62 pulmonary dysfunction 62 anaphylactoid reactions 62 valvular heart disease 62 arteriography 62 bullous 62 constipation nausea 62 hypoxemia 62 antidepressants fluoxetine 62 sustained ventricular tachycardia 62 chronic renal insufficiency 62 Erythropoietic therapies may 62 electrolyte abnormalities 62 Sleep disordered breathing 62 hypoglycemic events 62 angiographically 62 macular edema secondary 62 oral hypoglycemic agents 62 symptomatic ischemic 62 atrioventricular block 62 neurologic impairment 62 transaminase elevations 62 convulsive disorders 62 connective tissue disorders 62 intravitreal injections 62 histologic subtype 62 rebleeding 62 recurrent DVT 62 interstitial pneumonitis 62 hypertension diabetes mellitus 62 syncope fainting 62 revascularizations 62 β blockers 62 nonischemic 62 symptomatic hyponatremia 62 artery stenosis 62 epigastric pain 62 EEG abnormalities 62 neurologic sequelae 62 asplenia 62 dizziness headache nausea 62 hepatic enzymes 62 thymectomy 62 azoospermia 62 neurological abnormalities 62 anaphylactic reactions bronchospasm 62 intraoperative complications 61 hyperacute 61 lower extremity amputation 61 adnexal mass 61 covariate 61 affective psychoses 61 headache vomiting 61 erythema nodosum 61 pericardial effusions 61 primary hyperparathyroidism 61 inhaled bronchodilators 61 hemoglobinopathies 61 hypoglycaemic episodes 61 ischemic cerebrovascular 61 comorbid conditions 61 antiphospholipid syndrome 61 leucopenia 61 cerebrovascular accident 61 cerebral angiography 61 aneurysmal subarachnoid hemorrhage 61 arterial hypertension 61 pyelonephritis 61 onset seizures 61 somnolence dizziness 61 unstable angina pectoris 61 neutropenia febrile neutropenia 61 depressive symptomatology 61 cystic fibrosis chronic pancreatitis 61 reoperations 61 oxygen desaturation 61 serum aminotransferase levels 61 ventricular tachycardia VT 61 hepatorenal syndrome 61 fluoxetine paroxetine 61 posttransplant 61 hypovolemia 61 mania hypomania 61 arterial thromboembolic events 61 colorectal adenoma 61 anaphylaxis angioedema 61 hemorrhagic cystitis 61 Infusion Reactions Severe 61 hepatic metastases 61 vitamin B# folic acid 61 normotensive 61 hypomanic episodes 61 systemic corticosteroid 61 β blocker 61 GH deficiency 61 elevated LDH 61 decompensated cirrhosis 61 polyarticular 61 pathologic diagnosis 61 antiarrhythmic medications 61 hypercoagulable 61 coagulopathy 61 proximal DVT 61 nerve palsy 61 dysuria 61 pretransplant 61 hyperarousal 61 IPAH 61 comorbid 61 ß blockers 61 Clinically significant 61 onset diabetes mellitus 61 cough dyspnea 61 urticaria hives 61 T1c 61 P = .# 61 comorbid diagnoses 61 coronary artery occlusion 61 medically refractory 61 neutropenia dehydration dyspnea 61 neurosensory 61 morphometric vertebral fractures 61 occlusive disease 61 androgen ablation 61 amnestic 61 variant angina 61 dopaminergic therapy 61 coexisting illnesses 61 concomitant medications 61 acetabular fracture 61 timepoint 61 diarrhea flatulence 61 prospectively enrolled 61 cystoid macular edema 60 nonpsychotic 60 predisposing factor 60 lymphadenopathy 60 gastrointestinal adverse reactions 60 tachyarrhythmias 60 Venous thromboembolism 60 neurologic deficits 60 hematologic toxicity 60 percutaneous drainage 60 proctitis 60 cryptogenic 60 affective disorder 60 prolonged immobilization 60 TMP SMX 60 dysmotility 60 hypocalcemia 60 hyperalgesia 60 Comorbid 60 reintubation 60 comorbidities 60 choroidal neovascularization 60 symptomatic VTE 60 thromboprophylaxis 60 vesicoureteral reflux 60 cytopenia 60 LNG IUS 60 anterior temporal 60 syncopal episode 60 chest radiographs 60 lobar 60 elevated ALT 60 deep venous thromboses 60 bone marrow fibrosis 60 Cognitive impairment 60 corticosteroid therapy 60 anal incontinence 60 leiomyomas 60 androgen excess 60 cholecystitis 60 anemia thrombocytopenia 60 calculi 60 akinesia 60 preoperative evaluation 60 FluCAM arm 60 events TEAEs 60 electrolyte disturbances 60 pulmonary resection 60 hypopnea 60 dysthymic disorder 60 sequela 60 laboratory abnormalities 60 % CI #.#-#.# [008] 60 biochemical abnormalities 60 Clinical manifestations 60 adrenalectomy 60 ecchymosis 60 severe exacerbations 60 irregular menses 60 HIV HCV coinfected 60 salmeterol HFA MDI 60 clinically meaningful reductions 60 spirometric 60 pruritus rash 60 antiepileptics 60 rCBF 60 thromboembolic 60 CIMZIA TM certolizumab pegol 60 haematuria 60 reflux disease GERD 60 meta regression 60 somnolence sedation 60 Hurthle cell 60 esophageal reflux 60 genotypic resistance 60 comorbid psychiatric 60 oral anticoagulant therapy 60 esophageal gastric 60 elevated IOP 60 constipation predominant IBS 60 chorioamnionitis 60 nausea emesis 60 anemia leukopenia 60 underwent resection 60 hemoptysis 60 hypoglycemic episodes 60 poststroke 60 renal allograft 60 nonfatal MI 60 PLX STROKE targeting 60 rhinorrhea 60 impaired cognition 60 Heavy menstrual bleeding 60 hepatic renal 60 myoclonus 60 etiologies 60 manic hypomanic 60 intracerebral haemorrhage 60 aminotransferases 60 thrombophlebitis 60 hemodilution 60 comorbid disorders 60 stroke transient ischemic 60 myalgias 60 recurrent ischemia 60 vitreous floaters 60 OAB symptoms 60 CYP#D# inhibitor 60 comorbid anxiety 60 psychiatric comorbidity 60 severe hypersensitivity reactions 60 splenic 60 intracranial hypertension 60 relapsed MM 60 pamidronate 60 hematologic adverse 60 abdominal distension 59 enterocolitis 59 Eisenmenger syndrome 59 renal insufficiency 59 nadolol 59 cholestasis 59 syndromal 59 hypopituitarism 59 infarction NSTEMI 59 Subgroup analyzes 59 nonobese 59 Univariate analysis 59 sonographic appearance 59 eculizumab therapy 59 elevated transaminases 59 ischemic cardiomyopathy 59 Efficacy endpoints 59 % CI #.#-#.# [006] 59 schizophreniform disorder 59 hypothalamic pituitary 59 trastuzumab Herceptin ® 59 retransplantation 59 macrovascular events 59 noncardiac 59 electroencephalographic 59 surgical revascularization 59 thyrotoxicosis 59 neuropsychological impairments 59 chronicity 59 monoclonal gammopathy 59 oral antidiabetes drugs 59 malabsorptive 59 postoperative morbidity 59 ictal 59 LVSD 59 BPS IC 59 immunosuppressive regimen 59 gastroduodenal 59 pulmonary infiltrates 59 malignant polyps 59 neurological manifestations 59 dysmenorrhoea 59 cervical lymph nodes 59 hyperlipidaemia 59 depression suicidal ideation 59 preintervention 59 symptomatic intracranial 59 cardiomegaly 59 nephrolithiasis 59 fibroma 59 inhaled budesonide 59 Mood disorders 59 perioperative complications 59 somatoform disorders 59 cerebral ischemia 59 calcaneal fractures 59 testicular tumors 59 adenotonsillectomy 59 aldosterone antagonist 59 elevated lipase 59 concomitant AEDs 59 malignant neoplasms 59 subtrochanteric 59 mucosal inflammation 59 dyspnoea 59 premorbid 59 posttreatment 59 ventricular tachyarrhythmia 59 carotid artery blockage 59 fatigue diarrhea nausea 59 Adjuvant chemotherapy 59 tonsillar hypertrophy 59 delayed gastric emptying 59 Excessive daytime sleepiness 59 ICD shocks 59 dysrhythmias 59 detrusor 59 mycophenolate 59 airway hyperresponsiveness 59 folinic acid 59 fibroids endometriosis 59 antiarrhythmic drugs 59 renal kidney 59 hypercapnia 59 aspartate aminotransferase AST 59 epistaxis 59 thrombo embolic 59 asthenia fatigue 59 overactive bladder symptoms 59 sacral neuromodulation 59 obstructive coronary 59 metaplasia 59 MMSE score 59 neurocognitive functioning 59 conjunctival hyperemia 59 atherothrombotic 59 histologically confirmed 59 aortic insufficiency 59 recurrent sinusitis 59 hyperprolactinemia 59 hemodynamically stable 59 postinjury 59 pseudoaneurysms 59 comorbid illnesses 59 unknown etiology 59 Baseline characteristics 59 pheochromocytoma 59 autoimmune thyroiditis 59 coronary stenoses 59 drug eluting stent implantation 59 thrombophilia 59 arthrosis 59 bivariate analyzes 59 leukopenia 59 LV dysfunction 59 Tardive dyskinesia 59 nondiabetic subjects 59 percutaneous vertebroplasty 59 Contraindications 59 hamartoma 59 alpha interferons 59 abnormal ejaculation 59 peri procedural 59 radicular pain 59 gastro esophageal reflux 59 methotrexate therapy 59 Calcium intake 59 definite stent thrombosis 59 Atypical antipsychotics 59 acromegalic patients 59 voiding dysfunction 59 intracerebral 59 aromatase inhibitor therapy 59 neuropsychiatric symptoms 59 coronary revascularization 59 atelectasis 59 vasospasm 59 chills fever headache 59 n = 59 antiphospholipid antibodies 59 SRBD 59 thromboembolic complications 59 G6PD deficiency 59 acute aortic dissection 59 suppurative 59 histologic examination 59 diarrhea predominant IBS 59 ipsilateral breast 59 LV ejection fraction 59 neurologic complications 59 liver decompensation 59 appendiceal 59 PREZISTA r arm 59 hypervolemic hyponatremia 59 sensory neuropathy 59 HeFH 59 Renal impairment 59 hypoperfusion 59 pancytopenia 59 analgesic medications 59 pathologic fracture 59 CI #.#-#.# [001] 59 hepatic insufficiency 59 thyroid carcinoma 59 timepoints 59 headache dizziness fatigue 59 vasomotor 59 macroalbuminuria 59 impaired glucose metabolism 59 decubitus ulcers 59 gastrointestinal disturbances 59 cerebrovascular events 59 apnea hypopnea index 59 antiemetics 59 debilitating complication 58 neuroleptic 58 hypercholesterolaemia 58 polyposis 58 adverse cytogenetics 58 infarctions 58 prospectively stratified 58 amenorrhoea 58 osteoid 58 bleeding diathesis 58 temporal lobectomy 58 severe obstructive sleep 58 noncardiac chest pain 58 arterial occlusion 58 euthyroid 58 Torsades de Pointes 58 HbA 1c levels 58 virologic breakthrough 58 hepatic dysfunction 58 salmeterol fluticasone 58 extramedullary 58 multivariable analyzes 58 irritative 58 severe hypoglycaemia 58 VIIBRYD 58 rFVIIa 58 recurrent venous thromboembolism 58 asthenia 58 urethral strictures 58 detrusor overactivity 58 paroxysmal AF 58 ocular adverse 58 covariates 58 osteochondromas 58 hemorrhagic colitis 58 sepsis pneumonia 58 thromboembolism 58 immunocompetent patients 58 thrombocytosis 58 histologically proven 58 cerebral microbleeds 58 visceral metastases 58 denervation 58 subsyndromal 58 Subgroup analysis 58 Preoperatively 58 aminotransferase levels 58 mediastinitis 58 carcinoids 58 nonfatal pulmonary embolism 58 decompensated heart failure 58 pseudoaneurysm 58 arthralgias 58 Index CDAI 58 ATACAND 58 psychosocial variables 58 fibrinolysis 58 hypokalemia 58 multivessel disease 58 colorectal adenomas 58 PSA nadir 58 nonsevere 58 comorbid psychiatric disorders 58 IOP lowering 58 Toxicities 58 vascular endothelial dysfunction 58 nausea vomiting constipation 58 cranial irradiation 58 pyrexia mucositis sepsis febrile 58 endobronchial 58 familial aggregation 58 diarrhea nausea vomiting 58 paroxysmal 58 benign prostatic hypertrophy BPH 58 undetectable HBV DNA 58 polycythemia vera essential thrombocythemia 58 edema thrombosis pulmonary thromboembolism 58 Depressive symptoms 58 dyspareunia 58 fragility fracture 58 hepatic failure 58 psychiatric morbidity 58 sonographic examinations 58 decompensation 58 interstitial pneumonia 58 abdominal pain vomiting 58 gastrointestinal bleeds 58 polymorphic ventricular tachycardia 58 insomnia somnolence 58 included exfoliative dermatitis 58 multivariate adjustment 58 parkinsonian symptoms 58 intracranial hemorrhage ICH 58 hematopoietic cancers 58 septal defects 58 Cardiopulmonary bypass 58 left ventricular dysfunction 58 amisulpride 58 overnight polysomnography 58 flutamide 58 cerebral infarctions 58 Febrile neutropenia 58 diabetes mellitus hypertension 58 antiepileptic drugs AEDs 58 Myocardial infarction 58 intravenous bisphosphonates 58 transurethral resection 58 antiandrogen 58 Hypotension 58 osteochondroma 58 neuropsychological assessment 58 QTc intervals 58 TYSABRI treated 58 euthymic patients 58 events MACE 58 schizophrenia schizoaffective disorder 58 runny nose nasal congestion 58 lipid lowering medication 58 QT interval prolongation 58 caspofungin 58 extrapulmonary 58 neoplasm 58 hypoventilation 58 proliferative retinopathy 58 Hypertrophic 58 Sociodemographic 58 bowel perforations 58 valvular 58 atopic asthma 58 highest tertile 58 anatomical abnormalities 58 hypocalcaemia 58 neurodevelopmental outcome 58 hematologic parameters 58 hepatic cirrhosis 58 asthma exacerbation 58 serum lipid 58 renal cysts 58 Suicidal ideation 58 mg BID dose 58 etiologic factors 58 headaches nausea vomiting 58 hematological parameters 58 vein thrombosis 58 acute myocardial infarctions 58 hyperhomocysteinemia 58 supraventricular arrhythmias 58 radiochemotherapy 58 arteritis 58 myelosuppressive 58 postprocedure 58 calcineurin inhibitor 58 HAM D# 58 decompensated liver disease 58 diuretics beta blockers 58 somatoform disorder 58 hypercalciuria 58 orchitis 58 hypercalcaemia 58 convulsive seizures 58 AST ALT 58 hemorrhagic complications 58 pouchitis 58 anorexia cachexia 58 tibiofemoral 58 NMIBC 58 emotional lability 58 Helicobacter pylori eradication 58 nausea constipation 58 Tasigna prolongs 58 microdeletion 58 confusional 58 hypertensive retinopathy 58 tumor necrosis 58 plasma lipids 58 atherothrombosis 58 dermatologic reactions 58 Obstructive sleep apnea OSA 58 amenorrhea 58 hamartomas 58 sonographically guided 58 oropharyngeal 58 hypoactive 58 danazol 58 atherosclerotic renal artery stenosis 58 mild renal insufficiency 58 levodopa induced 58 prolactin elevation 58 extrapyramidal 58 lupus erythematosus 58 pathophysiologic 58 NSAID induced 58 neuritic 58 neurogenic bladder 58 Brief Psychiatric 58 underwent coronary angiography 58 esophageal perforation 58 chest radiography 58 carotid IMT 58 heparin induced thrombocytopenia 58 euthymic 58 silent ischemia 58 pravastatin therapy 58 mg Pycnogenol 58 dysglycemia 58 epididymitis 57 % CI #.#-#.# [007] 57 status epilepticus 57 anthracycline taxane 57 dyslipidaemia 57 metabolizer 57 intravenous cyclophosphamide 57 thyroidectomy 57 S. aureus sepsis 57 frequent awakenings 57 neutropenic fever 57 eosinophilia 57 chronic urticaria 57 #q# deletion syndrome 57 cardioembolic 57 extracranial 57 pulmonary artery banding 57 cough wheezing 57 surgically induced 57 venous thromboembolic disease 57 Comorbidities 57 dysplastic lesions 57 Postoperative 57 infective endocarditis 57 recurrent glioblastoma multiforme 57 SNHL 57 C1 INH deficiency 57 CVD mortality 57 bone scintigraphy 57 polytherapy 57 metabolic abnormalities 57 neurologic disorders 57 gastrointestinal hemorrhage 57 TNF antagonist 57 neurological sequelae 57 HF hospitalization 57 postoperative hemorrhage 57 MADRS score 57 acute hepatic 57 polyuria 57 papilledema 57 periprocedural 57 diastolic blood pressures 57 hypersomnia 57 tuberculous 57 SLNB 57 #mg/day [001] 57 gastro esophageal reflux disease 57 cardiovascular cerebrovascular 57 thrombocytopenic 57 symptomatology 57 chondral 57 diarrhea dyspepsia 57 anorexia nervosa bulimia 57 poststroke depression 57 revision THA 57 delirium convulsions 57 specific antigen PSA 57 diarrhea headache nausea 57 heart palpitations dizziness 57 nitrofurantoin 57 graft occlusion 57 Adverse events 57 patientswith 57 immune dysregulation 57 pooled comparator 57 ventricular fibrillation VF 57 Abdominal pain 57 ischemic cardiac 57 intracerebral hemorrhage ICH 57 ropivacaine 57 Lewy bodies DLB 57 pancreatic resection 57 infarcts 57 Epileptic seizures 57 echocardiographic parameters 57 intraventricular hemorrhage 57 rhythm disturbances 57 urinary albumin 57 pharmacologic treatments 57 adenomatous 57 adenomatous polyps 57 lumbar disk herniation 57 intima media thickness 57 neoplasias 57 urine cytology 57 umol L 57 Legg Calvé Perthes disease 57 acute respiratory tract infections 57 ribavirin therapy 57 breast abscesses 57 mL/min/#.# m 2 57 % CI #.#-#.# [003] 57 androgen deprivation 57 gait disturbance 57 ventricular repolarization 57 beta blocker therapy 57 lymph node enlargement 57 cerebral vascular 57 parenchymal 57 antiretroviral naïve 57 ipsilateral stroke 57 Key secondary endpoints 57 EXJADE 57 neoplastic 57 variceal bleeding 57 venous stasis ulcers 57 gallbladder disease 57 nonvertebral fracture 57 biliary obstruction 57 antidiabetic medications 57 systolic dysfunction 57 intravascular hemolysis 57 arthropathy 57 progressive dyspnea 57 constipation dizziness 57 hepatomegaly 57 somnolence fatigue 57 jugular venous 57 arterial thromboembolism 57 posttraumatic 57 neurocognitive impairment 57 nausea respiratory distress 57 risperidone Risperdal 57 hormonal abnormalities 57 thyrotropin levels 57 advanced adenomas 57 secondary efficacy endpoint 57 HBeAg 57 diastolic hypertension 57 moderate renal impairment 57 fatigue abdominal pain 57 headache arthralgia 57 atherogenic dyslipidemia 57 neovascular 57 cerebral vasospasm 57 ANCA associated 57 coronary revascularization procedures 57 monozygotic twin 57 oxycodone CR 57 androgen suppression 57 hematological toxicity 57 repolarization 57 mild renal impairment 57 acetabular dysplasia 57 PAOD 57 airway responsiveness 57 ventricular dilatation 57 lesional 57 nephrotoxic 57 acute tubular necrosis 57 gastro oesophageal reflux 57 chronic GVHD 57 psoriatic arthritis PsA 57 motor neuropathy 57 bacteriuria 57 hormonal deficiencies 57 Nausea vomiting 57 quetiapine Seroquel 57 aspirin NSAIDs 57 57 cholelithiasis 57 collagen vascular 57 hematuria 57 primidone 57 rheumatological 57 chronic renal disease 57 latent celiac disease 57 paroxetine Paxil 57 fluvastatin 57 total thyroidectomy 57 preterm newborns 57 thrombocytopenia neutropenia 57 BMI ≥ 57 cardiac malformations 57 myocardial infarction stroke 57 transaminase elevation 57 ziconotide 57 hyper IgE syndrome 57 polyp recurrence 57 thiopurine 57 elevated serum creatinine 57 postoperative infections 57 abacavir Ziagen 57 neurocognitive function 57 OSAHS 57 hepatic liver 57 mycophenolate mofetil MMF 57 recurrent acute pancreatitis 57 undergoing liver transplantation 57 axillary lymph node 57 primary dysmenorrhoea 57 Glucocorticoids 57 hepatocellular 57 microsatellite instability 57 neurocognitive deficits 57 CP CPPS 57 dermopathy 57 syncopal episodes 57 lung resections 57 NATRECOR ® 57 subconjunctival hemorrhage 57 mcg QD 57 nonrandomized 57 hypertrophic scars 57 elevated fasting glucose 57 subscale scores 57 hypometabolism 57 parasitemia 57 GLIADEL R Wafer 57 retinal edema 57 REYATAZ r arm 57 hypertension congestive heart 57 etiologic 57 thromboses 57 polydipsia 57 T1DM 57 vascular dysfunction 57 perinatal asphyxia 57 CANCIDAS 57 cortical atrophy 57 antidepressants SSRIs 57 atrophic gastritis 57 moderate hepatic impairment 57 multi infarct dementia 57 overt nephropathy 57 chronic thromboembolic pulmonary 57 carcinomatosis 57 oral Hycamtin 57 coagulation abnormalities 57 steroid refractory 57 familial clustering 57 sleep apneas 57 surgically resected 57 NSTEMI 57 angina chest 57 RLAI 57 cisplatin gemcitabine 57 lateral radiograph 57 Treatment discontinuations due 57 genitourinary GU 57 serum PTH 57 vasodilatation 57 cryptogenic stroke 57 aortic root replacement 57 hyperresponsiveness 57 dizziness somnolence 57 ejection fractions 57 acute mania 57 sleeve lobectomy 57 adrenal insufficiency 57 somatic symptoms 57 DMARDS 57 comorbid ADHD 57 venous thromboembolism VTE prophylaxis 57 hepatic encephalopathy HE 57 Avandia Actos 57 symptom exacerbation 57 femoral fracture 57 PASI scores 57 heterozygous familial 57 hyperparathyroidism 57 curative resection 57 hypervascular 57 idiopathic PAH 57 noncardiovascular mortality 57 pelvic lymphadenectomy 57 cytologic 57 primary aldosteronism 57 hyperinsulinemic euglycemic clamp 57 basilar 57 Symptom severity 57 dyslipidemias 57 partial remissions 57 acetylcysteine 57 plasma homocysteine 57 inotropes 57 Diabetic neuropathy 57 torsade de pointes 57 HBeAg positive patients 57 cholestatic 57 endometrial carcinoma 57 myocardial ischemia 57 Idiopathic 57 peripartum 57 edematous 57 skeletal metastases 57 cystic lesions 57 SGPT 57 parasomnias 57 HRQL 57 ischemic lesions 57 hypomagnesemia 57 meta analytic review

Back to home page